science

Regdanvimab

Regdanvimab is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Regdanvimab rather than just read about it. In short: Regdanvimab, sold under the brand name Regkirona, is a human monoclonal antibody used for the treatment of COVID-19. The antibody is directed against the spike protein of SARS-CoV-2.

Key takeaways

Regdanvimab belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Regdanvimab to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Regdanvimab from memory before moving on to harder problems.

Reference excerpt

Regdanvimab, sold under the brand name Regkirona, is a human monoclonal antibody used for the treatment of COVID-19. The antibody is directed against the spike protein of SARS-CoV-2. It is developed by Celltrion. The medicine is given by infusion (drip) into a vein. The most common side effects include infusion-related reactions, including allergic reactions and anaphylaxis. Regdanvimab was authorized for medical use in the European Union in November 2021.

Medical uses In the European Union, regdanvimab is indicated for the treatment of adults with COVID-19 who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19.

Society and culture

Legal status In March 2021, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) started a rolling review of data on regdanvimab. In October 2021, the EMA started evaluating an application for marketing authorization for the monoclonal antibody regdanvimab (Regkirona) to treat adults with COVID-19 who do not require supplemental oxygen therapy and who are at increased risk of progressing to severe COVID-19. The applicant is Celltrion Healthcare Hungary Kft. The European Medicines Agency (EMA) concluded that regdanvimab can be used for the treatment of confirmed COVID-19 in adults who do not require supplemental oxygen therapy and who are at high risk of progressing to severe COVID-19. In November 2021, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended granting a marketing authorization in the European Union for regdanvimab (Regkirona) for the treatment of COVID-19. The company that applied for authorization of Regkirona is Celltrion Healthcare Hungary Kft. Regdanvimab was authorized for medical use in the European Union in November 2021.

Names Regdanvimab is the international nonproprietary name (INN).

References

Further reading Kim C, Ryu DK, Lee J, Kim YI, Seo JM, Kim YG, et al. (January 2021). "A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein". Nature Communications. 12 (1): 288. doi:10.1038/s41467-020-20602-5. PMC 7803729. PMID 33436577. Syed YY (December 2021). "Regdanvimab: First Approval". Drugs. 81 (18): 2133–7. doi:10.1007/s40265-021-01626-7. PMC 8558754. PMID 34724174.

External links "Regdanvimab". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on 24 May 2022.

Worked examples

Example 1 — a first encounter with Regdanvimab

Start with the simplest possible case. Write down what Regdanvimab claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Regdanvimab before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Regdanvimab ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Regdanvimab

In research: Regdanvimab appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Regdanvimab in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Regdanvimab is common in secondary-school and first-year university syllabi. It links to neighbouring topics Antiviral drugs, COVID-19 drug development, Experimental antiviral drugs, so understanding it makes those chapters shorter.
In everyday life: Look for Regdanvimab outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Regdanvimab” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Regdanvimab in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Regdanvimab means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Regdanvimab out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Regdanvimab in simple terms?

Regdanvimab, sold under the brand name Regkirona, is a human monoclonal antibody used for the treatment of COVID-19. The antibody is directed against the spike protein of SARS-CoV-2.

Why does Regdanvimab matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Regdanvimab?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Regdanvimab.